INTEGRAL HEALTH ASSET MANAGEMENT, LLC Holdings

INTEGRAL HEALTH ASSET MANAGEMENT, LLC is an investment fund managing more than 514.78M US dollars. The largest holdings include Guardant Health, Cytokinetics, Incorporated and Elevance Health. In Q3 2022 the fund bought assets of total value of 203.32M US dollars and sold assets of total value of 196.81M US dollars.

$514.77M

portfolio value

+7.87%

quarter

-10.07%

1 year

INTEGRAL HEALTH ASSET MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	135921000	155363000
Q2 2020	177349000	86234000
Q3 2020	129006000	140474000
Q4 2020	140309000	121262000
Q1 2021	147160000	135461000
Q2 2021	146677000	130589000
Q3 2021	127965000	140707000
Q4 2021	137904000	128884000
Q1 2022	133670000	107063000
Q2 2022	212648000	107862000
Q3 2022	203322000	196810000

INTEGRAL HEALTH ASSET MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Diagnostics & Research Guardant Health, Inc. Portfolio share: 4.71% Portfolio value: 24.22M Avg. open price: $62.16 Current price: $51.95 P/L: -16.43% Bought +16.79% shares Q3 2022	share	4.71%	24.22M	$62.16	$51.95	-16.43%	Bought +16.79% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 4.29% Portfolio value: 22.10M Avg. open price: $27.15 Current price: $38.12 P/L: +40.43% N/A Q3 2022	call	4.29%	22.10M	$27.15	$38.12	+40.43%	N/A Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 3.53% Portfolio value: 18.17M Avg. open price: $491.22 Current price: $522.34 P/L: +6.34% Sold -41.04% shares Q3 2022	share	3.53%	18.17M	$491.22	$522.34	+6.34%	Sold -41.04% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 3.40% Portfolio value: 17.50M Avg. open price: $74.21 Current price: $86.35 P/L: +16.37% Sold -35.71% shares Q3 2022	share	3.40%	17.50M	$74.21	$86.35	+16.37%	Sold -35.71% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 3.29% Portfolio value: 16.95M Avg. open price: $27.15 Current price: $38.12 P/L: +40.43% Sold -33.33% shares Q3 2022	share	3.29%	16.95M	$27.15	$38.12	+40.43%	Sold -33.33% shares Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 3.14% Portfolio value: 16.15M Avg. open price: N/A Current price: $51.3 P/L: N/A N/A Q3 2022	share	3.14%	16.15M	N/A	$51.3	N/A	N/A Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 3.09% Portfolio value: 15.93M Avg. open price: $85.28 Current price: $110.01 P/L: +28.99% Bought +77.26% shares Q3 2022	share	3.09%	15.93M	$85.28	$110.01	+28.99%	Bought +77.26% shares Q3 2022
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 2.80% Portfolio value: 14.43M Avg. open price: $37.39 Current price: $33.51 P/L: -10.38% Bought +13.94% shares Q3 2022	share	2.80%	14.43M	$37.39	$33.51	-10.38%	Bought +13.94% shares Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 2.79% Portfolio value: 14.37M Avg. open price: $60.77 Current price: $52.11 P/L: -14.25% Bought +174.97% shares Q3 2022	share	2.79%	14.37M	$60.77	$52.11	-14.25%	Bought +174.97% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.72% Portfolio value: 14.01M Avg. open price: $137.59 Current price: $226.4 P/L: +64.55% Bought +49.04% shares Q3 2022	share	2.72%	14.01M	$137.59	$226.4	+64.55%	Bought +49.04% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 2.72% Portfolio value: 13.98M Avg. open price: $51.46 Current price: $43.52 P/L: -15.43% Sold -13.40% shares Q3 2022	share	2.72%	13.98M	$51.46	$43.52	-15.43%	Sold -13.40% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 2.63% Portfolio value: 13.55M Avg. open price: N/A Current price: $45.42 P/L: N/A N/A Q3 2022	share	2.63%	13.55M	N/A	$45.42	N/A	N/A Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 2.61% Portfolio value: 13.42M Avg. open price: $27.24 Current price: $18.36 P/L: -32.60% Bought +37.53% shares Q3 2022	share	2.61%	13.42M	$27.24	$18.36	-32.60%	Bought +37.53% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 2.59% Portfolio value: 13.35M Avg. open price: N/A Current price: $292.75 P/L: N/A N/A Q3 2022	share	2.59%	13.35M	N/A	$292.75	N/A	N/A Q3 2022
Medical Distribution Cardinal Health, Inc. Portfolio share: 2.59% Portfolio value: 13.33M Avg. open price: N/A Current price: $79.48 P/L: N/A N/A Q3 2022	share	2.59%	13.33M	N/A	$79.48	N/A	N/A Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 2.41% Portfolio value: 12.39M Avg. open price: $101.43 Current price: $102.01 P/L: +0.57% Sold -7.73% shares Q3 2022	share	2.41%	12.39M	$101.43	$102.01	+0.57%	Sold -7.73% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 2.31% Portfolio value: 11.91M Avg. open price: $46.27 Current price: $20.26 P/L: -56.21% Bought +61.65% shares Q3 2022	share	2.31%	11.91M	$46.27	$20.26	-56.21%	Bought +61.65% shares Q3 2022
Drug Manufacturers—Specialty & Generic Perrigo Company plc Portfolio share: 2.22% Portfolio value: 11.41M Avg. open price: $40.57 Current price: $31.81 P/L: -21.59% Bought +75.20% shares Q3 2022	share	2.22%	11.41M	$40.57	$31.81	-21.59%	Bought +75.20% shares Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 1.98% Portfolio value: 10.19M Avg. open price: $151.27 Current price: $382.44 P/L: +152.82% Sold -28.14% shares Q3 2022	share	1.98%	10.19M	$151.27	$382.44	+152.82%	Sold -28.14% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 1.86% Portfolio value: 9.55M Avg. open price: N/A Current price: $124 P/L: N/A N/A Q3 2022	share	1.86%	9.55M	N/A	$124	N/A	N/A Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 1.85% Portfolio value: 9.50M Avg. open price: N/A Current price: $44.93 P/L: N/A Sold -28.57% shares Q3 2022	share	1.85%	9.50M	N/A	$44.93	N/A	Sold -28.57% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.76% Portfolio value: 9.07M Avg. open price: $92.2 Current price: $103.53 P/L: +12.29% Sold -15.27% shares Q3 2022	share	1.76%	9.07M	$92.2	$103.53	+12.29%	Sold -15.27% shares Q3 2022
Biotechnology PTC Therapeutics, Inc. Portfolio share: 1.59% Portfolio value: 8.18M Avg. open price: $46.87 Current price: $41.12 P/L: -12.27% Bought +55.75% shares Q3 2022	share	1.59%	8.18M	$46.87	$41.12	-12.27%	Bought +55.75% shares Q3 2022
Biotechnology uniQure N.V. Portfolio share: 1.58% Portfolio value: 8.12M Avg. open price: $18.8 Current price: $25.65 P/L: +36.47% Bought +22.63% shares Q3 2022	share	1.58%	8.12M	$18.8	$25.65	+36.47%	Bought +22.63% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 1.57% Portfolio value: 8.08M Avg. open price: N/A Current price: $369.29 P/L: N/A Sold -65.78% shares Q3 2022	share	1.57%	8.08M	N/A	$369.29	N/A	Sold -65.78% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 1.52% Portfolio value: 7.83M Avg. open price: $18.28 Current price: $44.04 P/L: +140.86% Sold -20.15% shares Q3 2022	share	1.52%	7.83M	$18.28	$44.04	+140.86%	Sold -20.15% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 1.51% Portfolio value: 7.74M Avg. open price: N/A Current price: $267.97 P/L: N/A N/A Q3 2022	share	1.51%	7.74M	N/A	$267.97	N/A	N/A Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 1.47% Portfolio value: 7.57M Avg. open price: N/A Current price: $535.04 P/L: N/A N/A Q3 2022	share	1.47%	7.57M	N/A	$535.04	N/A	N/A Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.38% Portfolio value: 7.09M Avg. open price: N/A Current price: $234.96 P/L: N/A N/A Q3 2022	share	1.38%	7.09M	N/A	$234.96	N/A	N/A Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 1.36% Portfolio value: 6.99M Avg. open price: $67.34 Current price: $42.01 P/L: -37.61% Bought +49.71% shares Q3 2022	share	1.36%	6.99M	$67.34	$42.01	-37.61%	Bought +49.71% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 1.33% Portfolio value: 6.83M Avg. open price: $17.04 Current price: $15.82 P/L: -7.18% Bought +8.39% shares Q3 2022	share	1.33%	6.83M	$17.04	$15.82	-7.18%	Bought +8.39% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.31% Portfolio value: 6.72M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	share	1.31%	6.72M	N/A	$21.89	N/A	N/A Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 1.30% Portfolio value: 6.70M Avg. open price: $84.77 Current price: $44.6 P/L: -47.39% Sold -48.10% shares Q3 2022	share	1.30%	6.70M	$84.77	$44.6	-47.39%	Sold -48.10% shares Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 1.22% Portfolio value: 6.27M Avg. open price: $65.66 Current price: $75.78 P/L: +15.41% Bought +72.47% shares Q3 2022	share	1.22%	6.27M	$65.66	$75.78	+15.41%	Bought +72.47% shares Q3 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 1.22% Portfolio value: 6.26M Avg. open price: $117.39 Current price: $102.75 P/L: -12.47% Sold -12.90% shares Q3 2022	share	1.22%	6.26M	$117.39	$102.75	-12.47%	Sold -12.90% shares Q3 2022
Medical Care Facilities DaVita Inc. Portfolio share: 1.21% Portfolio value: 6.20M Avg. open price: $79.96 Current price: $73.45 P/L: -8.14% Bought +43.72% shares Q3 2022	share	1.21%	6.20M	$79.96	$73.45	-8.14%	Bought +43.72% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 1.19% Portfolio value: 6.12M Avg. open price: $91.32 Current price: $50.19 P/L: -45.04% Sold -28.46% shares Q3 2022	share	1.19%	6.12M	$91.32	$50.19	-45.04%	Sold -28.46% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 1.11% Portfolio value: 5.73M Avg. open price: $194.26 Current price: $302.43 P/L: +55.68% N/A Q3 2022	share	1.11%	5.73M	$194.26	$302.43	+55.68%	N/A Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 1.11% Portfolio value: 5.72M Avg. open price: N/A Current price: $213.86 P/L: N/A N/A Q3 2022	share	1.11%	5.72M	N/A	$213.86	N/A	N/A Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 1.04% Portfolio value: 5.35M Avg. open price: $15.58 Current price: $15.66 P/L: +0.49% Bought +18.89% shares Q3 2022	share	1.04%	5.35M	$15.58	$15.66	+0.49%	Bought +18.89% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.95% Portfolio value: 4.88M Avg. open price: $145.6 Current price: $92.75 P/L: -36.30% N/A Q3 2022	share	0.95%	4.88M	$145.6	$92.75	-36.30%	N/A Q3 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.95% Portfolio value: 4.87M Avg. open price: N/A Current price: $45.55 P/L: N/A N/A Q3 2022	share	0.95%	4.87M	N/A	$45.55	N/A	N/A Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.93% Portfolio value: 4.78M Avg. open price: $59.77 Current price: $49.41 P/L: -17.34% Sold -29.40% shares Q3 2022	share	0.93%	4.78M	$59.77	$49.41	-17.34%	Sold -29.40% shares Q3 2022
Medical Devices Nevro Corp. Portfolio share: 0.91% Portfolio value: 4.66M Avg. open price: $88.77 Current price: $43.47 P/L: -51.03% Bought +27.75% shares Q3 2022	share	0.91%	4.66M	$88.77	$43.47	-51.03%	Bought +27.75% shares Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.87% Portfolio value: 4.46M Avg. open price: $23.52 Current price: $25.51 P/L: +8.47% Sold -23.65% shares Q3 2022	share	0.87%	4.46M	$23.52	$25.51	+8.47%	Sold -23.65% shares Q3 2022
Biotechnology Revance Therapeutics, Inc. Portfolio share: 0.79% Portfolio value: 4.05M Avg. open price: N/A Current price: $21.1 P/L: N/A N/A Q3 2022	share	0.79%	4.05M	N/A	$21.1	N/A	N/A Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.72% Portfolio value: 3.71M Avg. open price: $32.87 Current price: $20.04 P/L: -39.03% Bought +24.56% shares Q3 2022	share	0.72%	3.71M	$32.87	$20.04	-39.03%	Bought +24.56% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.70% Portfolio value: 3.59M Avg. open price: N/A Current price: $9.29 P/L: N/A N/A Q3 2022	share	0.70%	3.59M	N/A	$9.29	N/A	N/A Q3 2022
Biotechnology Denali Therapeutics Inc. Portfolio share: 0.69% Portfolio value: 3.52M Avg. open price: $43.85 Current price: $30.94 P/L: -29.43% N/A Q3 2022	share	0.69%	3.52M	$43.85	$30.94	-29.43%	N/A Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 0.68% Portfolio value: 3.49M Avg. open price: $23.96 Current price: $12.08 P/L: -49.58% Bought +27.13% shares Q3 2022	share	0.68%	3.49M	$23.96	$12.08	-49.58%	Bought +27.13% shares Q3 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 0.68% Portfolio value: 3.49M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	0.68%	3.49M	N/A	$28.09	N/A	N/A Q3 2022
Medical Care Facilities LifeStance Health Group, Inc. Portfolio share: 0.68% Portfolio value: 3.47M Avg. open price: $8.3 Current price: $5.67 P/L: -31.68% Bought +39.73% shares Q3 2022	share	0.68%	3.47M	$8.3	$5.67	-31.68%	Bought +39.73% shares Q3 2022
Biotechnology Replimune Group, Inc. Portfolio share: 0.67% Portfolio value: 3.45M Avg. open price: $26.18 Current price: $19.95 P/L: -23.80% Sold -8.76% shares Q3 2022	share	0.67%	3.45M	$26.18	$19.95	-23.80%	Sold -8.76% shares Q3 2022
Biotechnology Forma Therapeutics Holdings, Inc. Portfolio share: 0.64% Portfolio value: 3.30M Avg. open price: $15.41 Current price: $20.01 P/L: +29.89% Sold -29.26% shares Q3 2022	share	0.64%	3.30M	$15.41	$20.01	+29.89%	Sold -29.26% shares Q3 2022
Medical Care Facilities Amedisys, Inc. Portfolio share: 0.62% Portfolio value: 3.19M Avg. open price: N/A Current price: $90.53 P/L: N/A N/A Q3 2022	share	0.62%	3.19M	N/A	$90.53	N/A	N/A Q3 2022
Biotechnology Heron Therapeutics, Inc. Portfolio share: 0.57% Portfolio value: 2.95M Avg. open price: $11.97 Current price: $2.54 P/L: -78.78% Sold -30.00% shares Q3 2022	share	0.57%	2.95M	$11.97	$2.54	-78.78%	Sold -30.00% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 0.55% Portfolio value: 2.82M Avg. open price: N/A Current price: $29.8 P/L: N/A N/A Q3 2022	share	0.55%	2.82M	N/A	$29.8	N/A	N/A Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 2.09M Avg. open price: N/A Current price: $13.67 P/L: N/A N/A Q3 2022	share	0.41%	2.09M	N/A	$13.67	N/A	N/A Q3 2022
Biotechnology Arcturus Therapeutics Holdings Inc. Portfolio share: 0.37% Portfolio value: 1.92M Avg. open price: $34.77 Current price: $17.69 P/L: -49.13% Sold -16.96% shares Q3 2022	share	0.37%	1.92M	$34.77	$17.69	-49.13%	Sold -16.96% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.36% Portfolio value: 1.85M Avg. open price: N/A Current price: $98.48 P/L: N/A N/A Q3 2022	share	0.36%	1.85M	N/A	$98.48	N/A	N/A Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 0.32% Portfolio value: 1.64M Avg. open price: $18.84 Current price: $12.33 P/L: -34.55% Bought +19.77% shares Q3 2022	share	0.32%	1.64M	$18.84	$12.33	-34.55%	Bought +19.77% shares Q3 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 1.35M Avg. open price: $9.67 Current price: $12.37 P/L: +27.87% Sold -81.55% shares Q3 2022	share	0.26%	1.35M	$9.67	$12.37	+27.87%	Sold -81.55% shares Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.20% Portfolio value: 1.05M Avg. open price: $18.76 Current price: $18.33 P/L: -2.29% Sold -71.82% shares Q3 2022	share	0.20%	1.05M	$18.76	$18.33	-2.29%	Sold -71.82% shares Q3 2022
Biotechnology Magenta Therapeutics, Inc. Portfolio share: 0.10% Portfolio value: 532K Avg. open price: $3.84 Current price: $1.24 P/L: -67.70% Bought +14.84% shares Q3 2022	share	0.10%	532K	$3.84	$1.24	-67.70%	Bought +14.84% shares Q3 2022
Biotechnology Longboard Pharmaceuticals, Inc. Portfolio share: 0.08% Portfolio value: 409K Avg. open price: $3.73 Current price: $4.75 P/L: +27.38% Bought +91.85% shares Q3 2022	share	0.08%	409K	$3.73	$4.75	+27.38%	Bought +91.85% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $150.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$150.97	N/A	Sold -100.00% shares Q3 2022
Biotechnology Kiniksa Pharmaceuticals, Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.25 Current price: $15.73 P/L: +39.85% Sold -100.00% shares Q3 2022	share	0.00%	0	$11.25	$15.73	+39.85%	Sold -100.00% shares Q3 2022
Medical Care Facilities agilon health, inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32.44 Current price: $17.7 P/L: -45.43% Sold -100.00% shares Q3 2022	share	0.00%	0	$32.44	$17.7	-45.43%	Sold -100.00% shares Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $204.76 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$204.76	N/A	Sold -100.00% shares Q3 2022
Biotechnology Moderna, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $175.93 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$175.93	N/A	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.06 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.06	N/A	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.51 Current price: $51.99 P/L: +65.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.51	$51.99	+65.01%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $61.19 Current price: $54.25 P/L: -11.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$61.19	$54.25	-11.34%	Sold -100.00% shares Q3 2022
Health Information Services 1Life Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $14.18 Current price: $16.74 P/L: +18.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$14.18	$16.74	+18.04%	Sold -100.00% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $116.56 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$116.56	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research PerkinElmer, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $120.25 Current price: $136.94 P/L: +13.88% Sold -100.00% shares Q3 2022	share	0.00%	0	$120.25	$136.94	+13.88%	Sold -100.00% shares Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $68.46 Current price: $39.62 P/L: -42.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$68.46	$39.62	-42.12%	Sold -100.00% shares Q3 2022
Biotechnology Atara Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.12 Current price: $4.65 P/L: -71.15% Sold -100.00% shares Q3 2022	share	0.00%	0	$16.12	$4.65	-71.15%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $66.34 Current price: $68.42 P/L: +3.14% Sold -100.00% shares Q3 2022	share	0.00%	0	$66.34	$68.42	+3.14%	Sold -100.00% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $121.22 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$121.22	N/A	Sold -100.00% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $158.57 Current price: $243.11 P/L: +53.31% Sold -100.00% shares Q3 2022	share	0.00%	0	$158.57	$243.11	+53.31%	Sold -100.00% shares Q3 2022
Health Information Services Teladoc Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $27.08 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$27.08	N/A	Sold -100.00% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $29.41 Current price: $19.89 P/L: -32.36% Sold -100.00% shares Q3 2022	share	0.00%	0	$29.41	$19.89	-32.36%	Sold -100.00% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$38.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $59.4 Current price: $33.74 P/L: -43.20% Sold -100.00% shares Q3 2022	share	0.00%	0	$59.4	$33.74	-43.20%	Sold -100.00% shares Q3 2022
Medical Devices Zimmer Biomet Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $140.93 Current price: $122.3 P/L: -13.22% Sold -100.00% shares Q3 2022	share	0.00%	0	$140.93	$122.3	-13.22%	Sold -100.00% shares Q3 2022
Biotechnology Lexicon Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.16 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.16	N/A	Sold -100.00% shares Q3 2022

Showing TOP 87 INTEGRAL HEALTH ASSET MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of INTEGRAL HEALTH ASSET MANAGEMENT, LLC?

The biggest position of the INTEGRAL HEALTH ASSET MANAGEMENT, LLC is Guardant Health, Inc. (GH) with 4.71% portfolio share worth of 24.22M US dollars.

Top 5 INTEGRAL HEALTH ASSET MANAGEMENT's holdings represent 19.23% of the portfolio:

Guardant Health, Inc. (GH) – 4.71%
Cytokinetics, Incorporated (CYTK) – 4.29%
Elevance Health Inc. (ELV) – 3.53%
Centene Corporation (CNC) – 3.4%
Cytokinetics, Incorporated (CYTK) – 3.29%

Who is the portfolio manager of INTEGRAL HEALTH ASSET MANAGEMENT, LLC?

The portfolio manager of the INTEGRAL HEALTH ASSET MANAGEMENT, LLC is .

What is the total asset value of the INTEGRAL HEALTH ASSET MANAGEMENT, LLC portfolio?

INTEGRAL HEALTH ASSET MANAGEMENT, LLC total asset value (portfolio value) is 514.78M US dollars.

Who is ?

is the portfolio manager of the INTEGRAL HEALTH ASSET MANAGEMENT, LLC.

What is (INTEGRAL HEALTH ASSET MANAGEMENT, LLC) fund performance?

INTEGRAL HEALTH ASSET MANAGEMENT's quarterly performance is +7.87%, annualy -10.07%.

What is the INTEGRAL HEALTH ASSET MANAGEMENT, LLC CIK?

INTEGRAL HEALTH ASSET MANAGEMENT's Central Index Key is 0001773206 .